WO2021060343A1
|
|
T-cell receptor expressed by human t-cells that recognize peptide derived from urlc10 or peptide derived from depdc1
|
TW202023581A
|
|
Cdca1-derived peptide and vaccine containing same
|
AU2018346765A1
|
|
Screening of T lymphocytes for cancer-specific antigens
|
TW201943715A
|
|
Bicyclic compound and use thereof for inhibiting histone methyltransferase
|
WO2018165112A1
|
|
Bicyclic compound and use thereof for inhibiting histone methyltransferase
|
TW201831503A
|
|
Mphosph1 epitope peptides for th1 cells and vaccines containing the same
|
TW201831502A
|
|
Depdc1 epitope peptides for th1 cells and vaccines containing the same
|
TW201827465A
|
|
Monoclonal antibody against fzd10 and use thereof
|
BR112019003408A2
|
|
monoclonal antibody against melk and its use
|
AU2016335731A1
|
|
FOXM1-derived peptide, and vaccine including same
|
BR112018006894A2
|
|
The vaccine containing MPHOSPH1 origin peptide and it
|
KR20180082432A
|
|
Bicyclic compound and its use for inhibiting SUV39H2
|
SG10201913592QA
|
|
Depdc1-derived peptide and vaccine containing same
|
TW201636358A
|
|
GPC3 epitope peptides for TH1 cells and vaccines containing the same
|
EP3178837A1
|
|
Urlc10-derived peptide and vaccine containing same
|
CA2956127A1
|
|
Koc1-derived peptide and vaccine including same
|
KR20170040315A
|
|
Cdca1-derived peptide and vaccine containing same
|
AU2015200800A1
|
|
Peptide Vaccines for Cancers Expressing Tumor-Associated Antigens
|
TW201829450A
|
|
Imp-3 epitope peptides for th1 cells and vaccines containing the same
|
WO2014141652A1
|
|
Smyd3 peptides and vaccines containing the same
|